Pancreatic Cancer Research

ResearcherUniversity of PennsylvaniaActive in the last 2 years

Yu‐Xiao Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0002-3690-9174; OpenAlex author ID A5042304706. Sources: OpenAlex.

Their work

Papers
17 (first author 0, last author 10)
Trials
0
Grants
1
Labs led
1
Collaborators
19
Papers, trials and grants by year

2013: 2 papers · 2014: 1 paper · 2015: none · 2016: 1 paper · 2017: 2 papers, 1 grant · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: 3 papers · 2023: 1 paper · 2024: 2 papers · 2025: 1 paper · 2026: 1 paper

Papers 17

  1. Leveraging the Electronic Health Record for Early Detection of Pancreatic Cancer Among 9.4 Million US Veterans. Co-author DOI 10.14309/ctg.0000000000000982↗
  2. Pancreatic Ductal Adenocarcinoma After Hepatitis C Infection. Co-author DOI 10.1001/jamanetworkopen.2025.43701↗
  3. Development and Validation of Case-Finding Algorithms to Identify Pancreatic Cancer in the Veterans Health Administration. Co-author DOI 10.1007/s10620-024-08324-w↗
  4. A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With Acute Pancreatitis. Last author DOI 10.1097/mpa.0000000000002295↗
  5. Do Polygenic Risk Scores Add to Clinical Data in Predicting Pancreatic Cancer? A Scoping Review. Co-author DOI 10.1158/1055-9965.epi-23-0468↗
  6. Cost-Effectiveness of a Risk-Tailored Pancreatic Cancer Early Detection Strategy Among Patients With New-Onset Diabetes. Last author DOI 10.1016/j.cgh.2021.10.037↗
  7. A clinical prediction model to assess risk for pancreatic cancer among patients with prediabetes. Last author DOI 10.1097/meg.0000000000002052↗
  8. Validation of the Enriching New-Onset Diabetes for Pancreatic Cancer Model: A Retrospective Cohort Study Using Real-World Data. Co-author DOI 10.1097/mpa.0000000000002000↗
  9. Digoxin use is associated with pancreatic cancer risk but does not affect survival. Last author DOI 10.1007/s10552-020-01352-7↗
  10. Assessing the effects of beta-blockers on pancreatic cancer risk: A nested case-control study. Co-author DOI 10.1002/pds.4993↗
  11. Total Serum Cholesterol and Pancreatic Cancer: A Nested Case-Control Study. Last author DOI 10.1158/1055-9965.epi-18-0421↗
  12. Proton pump inhibitors on pancreatic cancer risk and survival. Last author DOI 10.1016/j.canep.2016.12.006↗
  13. A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With New-Onset Diabetes. Last author DOI 10.1053/j.gastro.2016.11.046↗
  14. Impact of Metformin on Advanced Pancreatic Cancer Survival: Too Little, Too Late? Co-author DOI 10.1158/1078-0432.ccr-15-2494↗
  15. Diagnosis of pernicious anemia and the risk of pancreatic cancer. Last author DOI 10.1097/mpa.0000000000000054↗
  16. Type 2 diabetes mellitus and survival in pancreatic adenocarcinoma: a retrospective cohort study. Last author DOI 10.1002/cncr.27731↗
  17. Metformin and survival in pancreatic cancer: a retrospective cohort study. Last author DOI 10.1097/mpa.0b013e3182965a3c↗

Grants 1

  1. Validation of a Model Predicting Pancreatic Cancer in New-onset Diabetes AWARD pancan:2017-yu-xiao-yang-validation-of-a-model-predicting-pancrea

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Louise L. Wang · 6 shared papers, 2022–2026 · strength 1.40
  2. Ben Boursi · 8 shared papers, 2017–2022 · strength 1.11
  3. Amy C. Justice · 4 shared papers, 2023–2026 · strength 1.00
  4. Catherine Mezzacappa · 3 shared papers, 2023–2025 · strength 0.67
  5. Ronac Mamtani · 5 shared papers, 2017–2022 · strength 0.64
  6. Andrew D. Rhim · 3 shared papers, 2014–2022 · strength 0.29
  7. Kim A. Reiss · 2 shared papers, 2020–2022 · strength 0.27
  8. Rachel N. Levinson · 1 shared paper, 2025 · strength 0.23
  9. Sanjay M. Salgado · 1 shared paper, 2024 · strength 0.23
  10. Anil K. Rustgi · 2 shared papers, 2016–2017 · strength 0.20
  11. Gabriel Chodick · 1 shared paper, 2022 · strength 0.17
  12. William Chang-Yuen Chen · 1 shared paper, 2019 · strength 0.14
  13. Malcolm D. Kearns · 1 shared paper, 2017 · strength 0.12
  14. Allen L. Hwang · 2 shared papers, 2013 · strength 0.11
  15. Jeffrey D. Goldstein · 1 shared paper, 2020 · strength 0.09
  16. Talia Golan · 1 shared paper, 2020 · strength 0.09
  17. Akram Saad · 1 shared paper, 2020 · strength 0.09
  18. Yaacov Richard Lawrence · 1 shared paper, 2020 · strength 0.09
  19. Pari Shah · 1 shared paper, 2014 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.